News for Big Rock Partners Acquisition Corp. (BRPAU)

NEW YORK, July 18, 2023 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who...

/PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased NRx Pharmaceuticals Inc. (f/k/a Big...

NEW YORK, June 23, 2023 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entitie...

/PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased NRx Pharmaceuticals Inc. (f/k/a Big...

NRx Pharmaceuticals' shares have more than doubled off their mid-2022 sub-$1 lows as NRXP refocuses on its NRX-101 program. Read why the stock is a Hold.

NEW YORK, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NRx Pharmaceuticals, Inc. (“NRx” or the...

NRx Pharmaceuticals, Inc. (NASDAQ:NASDAQ:NRXP) Q2 2022 Earnings Conference Call August 15, 2022 08:30 AM ET Company Participants Tom Johnson - Investor Relations Stephen Willard - Chief...

According to Fortune Business Insights, the global Anxiety Disorders and Depression Treatment Market size is projected to reach USD 13.03 Billion in 2027,...

Dear Shareholders of NRx Pharmaceuticals, Inc. I am writing to you about the recent lawsuit Relief Therapeutics Holding AG and Relief Therapeutics International SA filed... | October 13, 2021